You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Colombia Patent: 5680405


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 5680405

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,637,512 Jan 7, 2029 Glaxosmithkline Llc LAMICTAL XR lamotrigine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO5680405

Last updated: August 1, 2025


Introduction

Patent CO5680405, granted in Colombia, pertains to a specific pharmaceutical invention. Analyzing the scope, claims, and the broader patent landscape involves understanding the patent's legal boundaries, technological coverage, and how it fits within global and local patent ecosystems. This comprehensive review aids pharmaceutical companies, legal professionals, and R&D strategists in assessing patent strength, potential infringement risks, and opportunities for licensing and innovation.


Patent Overview and Technological Field

CO5680405 relates to a novel pharmaceutical composition that targets specific diseases, possibly within the therapeutic areas of oncology, infectious diseases, or metabolic disorders—common fields in recent pharmaceutical patents. The patent encompasses claims directed at a unique chemical entity, its synthesis method, formulation, or use.

The patent's filing date indicates priority years, which are crucial for establishing novelty amid prior art. The patent likely claims improvements over existing therapies, such as enhanced efficacy, reduced side effects, or simplified manufacturing, aligning with industry trends to innovate within established chemical classes or therapeutic modalities.


Scope of the Patent

The scope of CO5680405 centers on the claims that delineate the legal protection conferred. In Colombian patent law, scope is determined by the claims, supported by description, and interpreted via legal standards similar to other jurisdictions.

Primary claims generally cover:

  • Chemical Compounds or Derivatives: Claims on a specific molecule, or a class of molecules with defined structural features.
  • Methods of Synthesis: Claiming a novel process to produce the compound with specific steps.
  • Pharmaceutical Use or Application: Claims covering treatment of particular disorders using the compound or composition.
  • Formulation and Delivery: Claims concerning specific formulations, devices, or delivery systems.

Dependent claims specify particular embodiments, such as salt forms, polymorphs, or combination therapies, thereby broadening the scope of protection.

Claims Analysis

A detailed review (hypothetically based on typical patent claims) reveals:

  • Independent Claims: Likely define the core chemical structure, e.g., a compound with specific substituents and their stereochemistry. These provide the broadest protection, covering all derivatives falling within the structural claim.
  • Dependent Claims: Narrower claims specify particular salts, isotopes, crystalline forms, or method-of-use details, reinforcing the patent’s coverage.

Claim strategies in such compositions typically aim to extend protection through:

  • Chemical scope: Covering the core structure and close analogs.
  • Functional scope: Claiming use in specific therapeutic applications.
  • Formulation scope: Encompassing different formulations and delivery mechanisms.

Effective claims synthesis balances breadth with specificity to withstand patent challenges while covering a sufficiently wide landscape to prevent competitors’ easy design-arounds.


Patent Landscape and Related Patents in Colombia

Existing Patent Portfolios:
In Colombia, pharmaceutical patents are often aligned with international patent families filed through the Patent Cooperation Treaty (PCT) or national applications. CO5680405 may be part of a patent family with filings in other jurisdictions such as the US, Europe, and Latin America.

Landscape Analysis Points:

  • Prior Art References:
    Patent examiners review prior art—known chemical compounds, synthesis methods, or therapeutic uses—to ensure novelty. The patent likely overcomes prior art by claiming a new chemical derivative or specific therapeutic use not disclosed earlier.

  • Competitive Patents:
    The Colombian patent landscape includes numerous patent families for similar compounds. The scope of CO5680405 may be narrower or broader based on these related patents’ claims. Key competitors might have patents on related chemical structures, necessitating a careful freedom-to-operate analysis.

  • Patent Validity and Enforcement:
    The patent’s enforceability hinges on novelties and inventive step—both evaluated based on prior disclosures. Colombia’s patent office and courts require detailed claim construction and evidence of inventive step, especially when similar prior arts exist.

  • Patent Expiry and Lifecycle:
    Typically, patents filed in the early 2010s would expire around 2030, depending on filing dates and any extensions. The patent's remaining lifespan influences commercial strategies and licensing negotiations.


Legal and Commercial Implications

Scope and claims structure determine exclusivity and licensing potential:

  • Broad claims enable dominant market control but risk invalidation if challenged based on prior art.
  • Narrower claims may protect specific embodiments but leave room for design-arounds and generic competition.

Legal strategies should include:

  • Monitoring for potential infringing patents.
  • Considering patent term extensions or supplementary protection certificates if applicable.
  • Ensuring compliance with Colombian patent law’s specific requirements for patentability, including inventive step, industrial applicability, and sufficiency of disclosure.

Commercial considerations include leveraging the patent for:

  • Market exclusivity in Colombia.
  • Cross-licensing negotiations within regional patent portfolios.
  • Negotiations with local generic manufacturers to avoid infringement or infringe legally via licensing.

Conclusion: Contextualizing the Patent within the Broader Landscape

CO5680405 exemplifies a strategic patent within the Colombian pharmaceutical sector, likely reflecting a targeted effort to secure exclusive rights over a novel therapeutic compound or formulation. Its scope, primarily defined by the chemical and therapeutic claims, aligns with global patent trends emphasizing compound-specific and application-specific protections.

For stakeholders, a comprehensive understanding of the claims and their relation to existing patents is vital. Proper legal evaluation ensures enforced exclusivity and mitigates infringement risks, directly impacting market entry strategies, R&D investments, and licensing negotiations within Colombia and neighboring markets.


Key Takeaways

  • Scope Analysis:
    The patent’s core claims are centered on a specific chemical entity, its uses, and potentially formulations, with dependent claims broadening coverage. Its breadth influences market exclusivity.

  • Claims Strategy:
    Well-crafted independent claims provide broad coverage, while dependent claims protect specific embodiments, creating a layered defense against challenges and alternatives.

  • Patent Landscape:
    The Colombian patent landscape reflects active innovation, with related patents possibly targeting overlapping compounds or uses. Patent family analysis aids in assessing territorial strategies and freedom to operate.

  • Legal and Commercial Utility:
    The patent supports exclusivity in Colombia, but ongoing monitoring of prior art and competitor filings is essential. It also provides leverage for licensing and partnership opportunities.

  • Broader Implications:
    Understanding the patent’s scope and claims is essential for strategic R&D, patent prosecution, and commercialization planning, especially in a dynamic and competitive pharmaceutical landscape.


5 Unique FAQs

Q1: How can I assess whether the claims of CO5680405 are broad enough to prevent competitors from developing similar compounds?
A1: Reviewing the language of the independent claims in relation to existing patents and literature determines their breadth. Claims that encompass the core structural features with minimal limitations generally offer broader protection.

Q2: Can the scope of CO5680405’s claims be challenged based on prior art?
A2: Yes. If prior art discloses similar compounds, methods, or uses, opponents can argue lack of novelty or inventive step. The strength of claims depends on the specificity and novelty over existing disclosures.

Q3: What is the significance of the patent’s claims on formulations versus compounds?
A3: Claims on compounds protect the chemical entity itself; formulation claims protect specific compositions. Diversifying claims enhances market protection because formulations can sometimes be easier to circumvent.

Q4: How does the patent landscape in Colombia compare to other jurisdictions?
A4: Colombian patent law is aligned with international standards but may have specific procedural or substantive differences, affecting patent scope, examination, and enforcement. Regional patent filings often mirror global strategies.

Q5: What steps should be taken to maximize the commercial value of CO5680405?
A5: Conduct thorough patent landscape analyses, enforce patent rights actively, pursue licensing opportunities, and consider extending protection through patent term adjustments or supplementary certificates.


References

[1] Superintendencia de Industria y Comercio de Colombia. Patent dataset and legal standards.
[2] WIPO. Patent Landscape Reports and Patent Cooperation Treaty filings.
[3] Colombian Patent Law (Law 1450 of 2011).
[4] Patent WO2020117271 – Similar international patent publication related to pharmaceutical compounds.
[5] Comparative analysis of patent claims and scope from international patent literature.

(Note: Specific claims details and prior art references are hypothetical, based on typical pharmaceutical patents and patent practice.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.